Membrane bioreactor for pharmaceutically active compounds removal: Effects of carbamazepine on mixed microbial communities implied in the treatment

Process Biochemistry

Volumn 45, Issue 11, 2010, Pages 1826-1831

  Aubenneau, Michael ^a   Tahar, Alexandre ^a   Casellas, Claude ^b   Wisniewski, Christelle ^a  

^a CIRAD   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Activated sludge; Carbamazepine; Membrane bioreactor; Micropollutants; Respirometry

Indexed keywords

ACTIVATED SLUDGE; CARBAMAZEPINE; MEMBRANE BIOREACTOR; MICROPOLLUTANTS; RESPIROMETRY;

AMIDES; BACTERIOLOGY; BATCH REACTORS; BIOCONVERSION; BIOREACTORS; OXYGEN;

ACTIVATED SLUDGE PROCESS;

BACTERIA (MICROORGANISMS);

EID: 77957744274     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2010.04.011     Document Type: Article

References (27)

1. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ Sci Technol 2006, 40:357-363.
2. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
3. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 2005, 39:3139-3152.
4. Halling-Sørensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lüzhøt H.C.H., Jøgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 1998, 32:357-393.
5. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
6. Heberer T., Reddersen K., Mechlinski A. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol 2002, 46:81-88.
7. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., et al. Diclofenac residues 2004.
8. Radjenovic J., Jelić A., Petrović M., Barceló D. Determination of pharmaceuticals in sewage sludge by pressurized liquid extraction (PLE) coupled to liquid chromatography-tandem mass spectrometry (LC-MS/MS). Anal Bioanal Chem 2009, 393(6-7):1685-1695.
9. Lesjean B., Gnirrs R., Buisson H., Keller S., Tazi-Pain A., Luck F. Outcome of a 2-year investigation on enhanced biological nutrients removal and trace organic elimination in membrane bioreactor (MBR). Water Sci Technol 2005, 52:453-460.
10. Kimura K., Hara H., Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 2007, 41:3708-3714.
11. Gobel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behaviour of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 2005, 39:3981-3989.
12. Perez S., Barcelo D. Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites. TrAC Trends in Analytical Chemistry 2008, 27(November (10)):836-846.
13. Bott C.B., Love N.G. The immunochemical detection of stress proteins in activated sludge exposed to toxic chemicals. Water Res 2001, 35(1):91-100.
14. Paxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 2004, 50:253-260.
15. Delgado L.F., Schetrite S., Gonzales C., Albasi C. Effect of cytostatic drugs on microbial behaviour in membrane bioreactor system. Bioresour Technol 2010, 101(2):527-536.
16. Wishart D.S., Knox C., Guo A.C., Shrivastava S., Hassanali M., Stothard P., et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 2006, 34:D668-D672.
17. Reith D.M., Appleton D.B., Hooper W., Eadie M.J. The effect of body size on the metabolic clearance of carbamazepine. Biopharm Drug Dispos 2000, 21:103-111.
18. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
19. APHA. Standard Methods for the Examination of Water and Wastewater, 21st edition; 2005.
20. Henriques I.D.S., Holbrook D., Kelly I.I., Richard T., Love N.G. The impact of flocs size on respiration inhibition by soluble toxicants-a comparative investigation. Water Res 2005, 39:2559-2568.
21. Kraigher B., Kosjek T., Heath E., Kompare B., Mandic-Mulec I. Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors. Water Res 2008, 42(November (17)):4578-4588.
22. Pitter P., Chudoba J. Biodegradability of organic substances in the aquatic environment 1990, CRC Press, Boca Raton, FL, USA, p. 7-83.
23. Topalova Y., Kozuharov D., Dimkov R. Adaptive response of trivial activated sludge towards toxic e.ect of oNP, PCP and combination oNP/PCP. Waste Manage 1999, 19:247-254.
24. Wang S., Holzem R.M., Gunsch C.K. Effects of pharmaceutically active compounds on a mixed microbial community originating from a municipal wastewater treatment plant. Environ Sci Technol 2008, 42:1091-1095.
25. Love N.G., Bott C.B. Evaluating the role of microbial stress response mechanisms in causing biological treatment system upset. Water Sci Technol 2002, 46(1-2):11-18.
26. Paxéus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, b-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci Technol 2004, 50:253-260.
27. Katja H., Mika S. Flocculation in Paper and Pulp Mill Sludge Process. Res J Chem Environ 2007, 11(3):96-103.